SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012574
Filing Date
2017-11-08
Accepted
2017-11-08 09:01:42
Documents
66
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 527731
2 ex31-1.htm EX-31.1 22872
3 ex31-2.htm EX-31.2 21462
4 ex32-1.htm EX-32.1 7287
5 ex32-2.htm EX-32.2 7323
  Complete submission text file 0001493152-17-012574.txt   3288471

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE crbp-20170930.xml EX-101.INS 450993
7 XBRL SCHEMA FILE crbp-20170930.xsd EX-101.SCH 42408
8 XBRL CALCULATION FILE crbp-20170930_cal.xml EX-101.CAL 61409
9 XBRL DEFINITION FILE crbp-20170930_def.xml EX-101.DEF 166701
10 XBRL LABEL FILE crbp-20170930_lab.xml EX-101.LAB 309709
11 XBRL PRESENTATION FILE crbp-20170930_pre.xml EX-101.PRE 253652
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 171185256
SIC: 2834 Pharmaceutical Preparations